Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine and Fentanyl vs IV Midazolam and Ketamine for Procedural Sedation
NCT04621110Phase 3Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine and fentanyl citrate nasal spray in procedural pain (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Pain control assessed by FLACC scale up to 30 minutes, Sedation assessed by Ramsay scale up to 30 minutes and 3 more. Status: unknown.
02
Drugs
dexmedetomidinefentanyl citrate nasal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04621110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621110.